☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Lupin Entered into an Exclusive License and Supply Agreement with DKSH to Commercialize Five Biosimilar Candidates in the Philippi...
September 7, 2022
Pfizer’s PF-06760805 Receives the US FDA’s Breakthrough Therapy Designation for the Prevention of Infection in Infants
September 7, 2022
Carsten Linnemann, CEO at Neogene Therapeutics Shares Insights on the Approval of CTA for the P-I Trial of its TCR Therapy to Trea...
September 7, 2022
Zealand Entered into a License and Development Agreement with Novo Nordisk for Zegalogue (dasiglucagon) to Treat Diabetes
September 7, 2022
Ionis and AstraZeneca Present P-III (NEURO-TTRansform) Study Results of Eplontersen for Hereditary Transthyretin-Mediated Amyloid...
September 7, 2022
AstraZeneca Presents (XALOC) Programme Results of Fasenra (benralizumab) for the Treatment of Severe Eosinophilic Asthma at ERS 20...
September 7, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions